Dr. Myers started at the Cleveland Clinic in June of 2018. His role is new to the clinic and encompasses leadership of the ambulatory practices, community internal medicine, geriatrics, community pediatrics, family medicine, hospital medicine, express care, post-acute medicine, ambulatory pharmacy, medical care@home, distance health, the ACO structure, the 6000 member clinically integrated network, wellness, integrative medicine, executive health, three residency programs, ambulatory behavioral medicine, the employee health plan, as well as the center for value based research.

Prior to joining the clinic, Dr. Myers served as Chief Medical Officer and Chief Operating Officer of Texas Health Physicians Group, a 1000-member multispecialty group affiliated with Texas Health Resources. Dr. Myers also served as chair of clinical integration for a 3000 member joint venture CIN with UTSW called Southwestern Health Resources.

A New York City native, Myers is board-certified in family medicine and was in private practice in Oklahoma for more than 10 years. He also served on faculty in the University of Oklahoma Obstetrics and Gynecology department for 7 years teaching obstetrics before moving to Dallas in 2010 to serve as chief medical officer and senior vice president for Methodist Health System. He currently serves as Chair of the American Hospital Association board level Committee for Clinical Leadership.
Myers is an accomplished clinician, business leader, author and humanitarian. He has earned numerous professional credentials including the status of Fellow with the American College of Healthcare Executives, The American Institute of Healthcare Quality and the American Association of Family Physicians. He holds additional board certification in healthcare quality management and patient safety, and he’s a certified professional in healthcare risk management.

Myers received his undergraduate degree from Centenary College of Louisiana in Shreveport, where he graduated from Louisiana State University Medical Center. He completed his residency with In His Image Family Practice Residency at Hillcrest Medical Center in Tulsa, Okla., and has completed fellowship work at the University of Oklahoma Obstetrics and Gynecology Department. He also completed a Masters in Health Care Management from Harvard University.

Contact Information:

Adrienne Boissy, MD, MA, is Chief Experience Officer of Cleveland Clinic Health System, and a staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis with a secondary appointment in the Center for Ethics, Humanities and Spiritual Care. As Chief Experience Officer, Dr. Boissy leads the Office of Patient Experience and its initiatives to improve the patient experience across Cleveland Clinic Health System.

Dr. Boissy previously served as the Medical Director of the Center of Excellence in Healthcare Communication. Her team created a comprehensive program to strengthen physician and provider communication skills throughout Cleveland Clinic and has trained more than 4,000 staff physicians and house staff to date.

Dr. Boissy also guided the development of patient advisory councils across Cleveland Clinic Health System and is active in the Cleveland Clinic Professionalism Council. She currently serves as Editor-in-Chief of the Journal of Patient Experience.

As part of her clinical work, Dr. Boissy focuses on ethical issues in neurological disease. She served on the Cleveland Clinic Ethics Committee and is the Assistant Clinical Director in the Center for Neuroethics. She has been published in Neurocritical Care, AAN Continuum and Neurology regarding the humane treatment of critically ill patients and communication challenges in clinical practice. In particular, she has a special interest in the words clinicians choose when conveying information, and the risks and ethics of what she calls “therapeutic mislabeling” versus truth telling.

Dr. Boissy was awarded a Sylvia Lawry Fellowship grant from the National Multiple Sclerosis Society and an Arnold P. Gold Foundation grant for humanism in medicine. She also serves on the editorial board of the National Multiple Sclerosis Society’s Momentum Magazine.

Dr. Boissy also is a Harvard Macy scholar. She has spoken extensively around the country about the patient and provider experience and the impact of effective communication on both.

Dr. Boissy attended Boston University and worked in neurobiological research at Brigham and Women’s Hospital, Boston. She completed her medical school training at Pennsylvania State University College of Medicine and finished her neurology residency and neuroimmunology fellowship at Cleveland Clinic. She completed a master’s degree in bioethics from Case Western Reserve University, Cleveland.

Contact Information:

Dr. Saklecha is the Managing Director of Cleveland Clinic Ventures where he leads investments into startup companies for one of the world’s top healthcare systems. He currently sits on the boards of Cardionomic, Cleveland Diagnostics, Enhale Medical, Enspire DBS, Mitria Medical, Navigate Cardiac Structures, Neurotherapia, and Zehna Therapeutics.
 
Prior to joining Cleveland Clinic Ventures, Akhil was a Partner at Artiman Ventures, a Silicon Valley-based venture capital firm with over $1.2 billion under management. While at Artiman, he led investments in early-stage start-up companies and served on the boards of Cellmax Life, Oncostem Diagnostics, Slive, ApplyBoard, DateMySchool, and HomeUnion. In addition to his Board of Director roles, he also served as CEO of Slive, an early stage diagnostics company. Prior to joining Artiman, Akhil served in administrative roles at Aultman Hospital in Ohio as Medical Director of the hospital’s regional transfer program and Chairman of the Emergency Department and Level II Trauma Center. He was also CEO of Canton Aultman Emergency Physicians, a professional services firm that provides physicians, mid-level providers, and coding expertise to multiple hospitals and urgent care centers. In this same time period, Akhil participated at the local, state, and national levels of governing institutions within emergency medicine, healthcare quality, information technology, managed care, and emergency medical services.
 
Akhil is Board-certified in Emergency Medicine and is a Fellow of the American College of Emergency Physicians. He continues to practice emergency medicine at Cleveland Clinic on a part-time basis where he remains connected to clinical care, patients, and physicians. Akhil graduated from the combined accelerated B.S./M.D. program at Northeast Ohio Medical University. He completed his residency in Emergency Medicine at Summa Health System and holds a M.B.A. from the University of Tennessee at Knoxville.
 

Contact Information:

Alexis Ji joined Illumina Ventures as a partner in 2016. She brings 12 years of experience in research and venture investment in the genomics and pharmaceutical industries. At Illumina Ventures, Alexis focuses on investing in early-stage genomics technology platforms and applications in life science tools, diagnostics, therapeutics, and digital health.

Prior to Illumina Ventures, Alexis was a principal at WuXi Apptec Corporate Venture Fund and then WuXi Healthcare Ventures, a U.S.-China cross-border life science venture capital firm, where she focused on investments in therapeutics and medtech companies in the U.S. Alexis was instrumental in investments in Twist Bioscience, 23andme, Juno Therapeutics, Syros Pharmaceuticals, Unity Biotechnology, Vivace Therapeutics, Medeor Therapeutics, Ideaya Therapeutics, and Lumo Bodytech. Before joining WuXi, Alexis was a venture investment consultant at ARCH Venture Partners, where she evaluated early-stage life science and physical science opportunities and was involved in the founding of Twist Bioscience and the investment in Nextcode Health, and provided operating assistance to Boreal Genomics and PixelEXX Systems.
 
Earlier in her career, Alexis worked as a senior scientist at Merck in early drug discovery, at Roche in virology translational research and clinical trial development, and at Life Technologies in molecular diagnostics and next-generation sequencing.

Alexis earned her Ph.D. in Molecular Genetics from Washington University in St. Louis, where her thesis was on non-coding RNA discovery. Alexis holds an MBA from University of Chicago Booth School of Business, and a Bachelor in Biochemistry from Shandong University
 

Contact Information:

ALISTAIR ERSKINE, MD is the Chief Digital Health Officer at Massachusetts General Brigham, teaching hospitals for Harvard Medical School.  He is responsible for sequencing innovative technologies, harmonizing data across the clinical care, research and health plan enterprise, and aligning digital patient experience with emerging patient consumerism trends.  Dr. Erskine leads the Digital Health department responsible the design and configuration of Mass General Brigham's clinical information systems and virtual care services.  He also leads the Enterprise Data & Digital Health program, a targeted five-year initiative to advance foundational investments in digital patient and clinician experience, system operations, and clinical care to enable Mass General Brigham to engage across local, national and global markets. 
 
Prior to Mass General Brigham, Dr. Erskine was Geisinger Health’s Chief Informatics Officer and oversaw Geisinger’s Unified Data Architecture, a hedged data management environment powered by Hadoop/Big Data and traditional relational database systems. In previous roles, he was appointed to the Virginia Governor’s Health Information Technology Commission by Executive Order and was a voting member of the Health Information Technology Standards Committee.  He presents and publishes on the topic of digital health, clinical transformation and virtual care in peer-reviewed literature and serves on Boards of several companies.  

Dr. Erskine trained at Brown University and Virginia Commonwealth University Health System and is triple Board-Certified in Internal Medicine, Clinical Informatics and Pediatrics.  He completed a two-year degree program at MIT Sloan School of Management, with a specialization in Business Analytics and Artificial Intelligence. He has been practicing hospital medicine for 15 years and teaches at Harvard Medical School. 
 

Contact Information:

Angela Yochem is EVP & Chief Digital and Technology Officer for Novant Health, a super-regional healthcare system with one of the largest medical groups in the US. She and her teams deliver the world-class consumer capabilities, differentiating technologies, and advanced clinical solutions that allow the high-growth system to provide remarkable patient care.

Angela has served as EVP/CIO at Rent-A-Center, Global CIO at BDP International, Global CTO at AstraZeneca, and divisional CIO at Dell. She’s held tech exec roles at Bank of America and SunTrust, and held senior technology roles at UPS and IBM. In these roles, she built B2B digital product lines, grew digital retail channels (B2C), created technical services lines of business, and transformed global technology capabilities. 

Angela is an Independent Director with Zurich American Insurance Group, and has been a Director for the Federal Home Loan Bank of Pittsburgh, BDP Transport, BDP Global Services Asia and Europe, and Rocana, with experience on Audit, Enterprise Risk, Operational Risk, and Governance/Policy committees. She remains an Entrepreneur in Residence, Mentor, and Advisor for venture groups and incubators on both US coasts. Angela serves on the board of Freedom School Partners, a non-profit committed to promoting literacy in the Charlotte area, and co-chairs the executive team of the Go Red for Women Charlotte organization, part of the American Heart Association. She is a Trustee of the Charlotte Regional Business Initiative, and is an advisory board member for the American Hospital Association Innovation Council, the University of Tennessee Electrical Engineering and Computer Science department, and the University of North Carolina Charlotte College of Computing and Informatics. 

Angela has a Bachelor of Music from DePauw University and a Master of Science in Computer Science from the University of Tennessee, holds three US Patents and is an author with Addison-Wesley and Prentice-Hall. 
 

Contact Information:

Anne Klibanski, M.D. is the President and Chief Executive Officer of Mass General Brigham, a Boston-based integrated health care system that includes internationally known Brigham and Women’s Hospital and Massachusetts General Hospital, nationally recognized specialty hospitals including Spaulding, Mass Eye and Ear, and McLean, seven community hospitals, a health insurance company, physician networks, community health centers, home care and long-term care services. The largest private employer in Massachusetts with 78,000 employees and annual revenue of $13.4 billion, the non-profit health care system is the nation’s leading recipient of NIH funding and a principal teaching affiliate of Harvard Medical School, establishing the health care system’s position as a national leader in medical research and teaching.
 
Appointed to her role as President and CEO in June 2019, Dr. Klibanski’s vision for Mass General Brigham is to build the integrated academic health care system of the future with patients at the center, transforming care, improving outcomes and expanding impact locally, nationally and globally.
 
Dr. Klibanski has served as the health care system’s Chief Academic Officer and as Chief of Neuroendocrine at Massachusetts General Hospital. She is recognized internationally for her high impact research in neuroendocrine disorders and pituitary tumors.  Dr. Klibanski received her B.A., magna cum laude in literature from Barnard College and her M.D. from New York University Medical Center. She is the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School.
 

Contact Information:

Dr. Beri Ridgeway is the Institute Chair of the Obstetrics, Gynecology, and Women’s Health Institute at Cleveland Clinic and the inaugural academic chair for the Cleveland Clinic Lerner College of Medicine Department of OB, GYN, and Reproductive Biology. She attended medical school at the University of California, San Francisco and completed a four-year residency in Obstetrics and Gynecology at University of California, San Diego. She then went on to complete a three-year fellowship in Female Pelvic Medicine and Reconstructive Surgery and Minimally Invasive Surgery at Cleveland Clinic.

Dr. Ridgeway leads nearly 600 physicians and caregivers providing basic and advanced women’s health medical care to women in Northeast Ohio and beyond. In 2019, her department completed over 400,000 visits, 10,000 deliveries, and 8,400 surgeries. In addition to clinical service, they provided education to the next generation of physicians, including 25 residents and 13 fellows. In the last year, Dr. Ridgeway expanded the residency program and added two new fellowships.

Dr. Ridgeway is currently serving as an Associate Chief of Staff. She was involved in the first responses to COVID and developed a team to wind down surgical services in preparation for the surge of COVID patients. Currently, she is leading teams dedicated to clinical reactivation in order to not further defer care for non-COVID patients. In these efforts, she oversees initiatives to increase access for patients via surgical cases, face-to-face visits, and telehealth. Dr. Ridgeway has authored more than 70 peer-reviewed articles and 10 book chapters and made numerous presentations at national and international meetings. Her research interests include surgical correction of pelvic organ prolapse, uterine-sparing operations to treat prolapse, and combined pelvic floor disorders.

Contact Information:

Xaralambos Zervos, DO is a graduate of Barry University where he received a Masters in Science, he then continued his medical education at Nova Southeastern College of Osteopathic Medicine where he received his medical degree. Dr. Zervos carried out his postgraduate training at various medical centers. He participated in an internship and residency in internal medicine at UPMC Mercy Hospital of Pittsburg, a residency at Mount Sinai Medical Center, and two fellowships in gastroenterology and hepatology at the University of Miami School of Medicine-Jackson Memorial hospital. In 2013, Dr. Zervos joined Cleveland Clinic Florida as a board-certified internist with specialties in gastroenterology and hepatology and serves as Associate Medical Director for Transplantation.

Contact Information:

Brian Bolwell, MD is Chairman of Taussig Cancer Institute, Cleveland Clinic Cancer Center.  As Chairman, he is responsible for all clinical, financial, academic, operational, professional, and strategic issues pertaining to cancer medicine at Cleveland Clinic.  Dr. Bolwell oversees a staff of over 140 physicians, both at the main campus and at many regional centers. He was Director of the Cleveland Clinic Bone Marrow Transplant Program for 24 years, and Chairman of the Department of Hematologic Oncology & Blood Disorders from 2006-2011.  He has authored over 450 articles and abstracts concerning bone marrow transplantation, lymphoma, and other hematologic malignancies.  Dr. Bolwell has edited the textbook “Current Controversies of Bone Marrow Transplantation” (Humana Press, 2000), and is co-editor of the textbook “Clinical Malignant Hematology” (McGraw Hill, 2007).  Dr. Bolwell is an ad hoc reviewer for the Journal of Clinical Oncology, Bone Marrow Transplantation, Blood, Annals of Internal Medicine, and many other scientific periodicals.  Dr. Bolwell has served as a grant reviewer for the National Cancer Institute on multiple occasions.  He has also served on leadership committees for the American Society of Hematology (ASH) and the Center for International Bone Marrow Transplantation Research (CIBMTR). 

Dr. Bolwell is also a Professor of Medicine for Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, and Deputy Director of the Case Comprehensive Cancer Center.   

Contact Information:

Brian G. Donley, M.D. Dr. Brian Donley began his new role as Chief Executive Officer of Cleveland Clinic London in February 2018. Prior to this appointment, he was the Chief of Staff and Chief of the Clinical Enterprise for the Cleveland Clinic Health System beginning in January 2015. Previous to that, he served as President of Regional Operations for the Cleveland Clinic Health System overseeing 10 Regional Hospitals and eighteen Family Health Centers. Dr. Donley is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. He attended the University of Notre Dame for his undergraduate studies, graduating Phi Beta Kappa. He graduated With Distinction from the University of Michigan Medical School and completed his residency in orthopaedic surgery at the University of Michigan. Dr. Donley completed a fellowship in orthopaedic foot and ankle surgery at the Campbell Clinic in Memphis, TN. He also attended Harvard Business School completing the Advanced Management Program. He joined Cleveland Clinic’s Orthopaedic & Rheumatologic Institute in 1996, serving in various roles over the years, including Vice Chairman of the Department of Orthopaedics, Director of the Foot and Ankle Fellowship, and Director of Research and Education for Foot and Ankle Surgery. He was team physician for the Cleveland Browns professional football team and has been an orthopaedic consultant for many professional sports teams. In 2007, he was chosen to the prestigious American-British-Canadian travelling fellowship that provided an opportunity for Dr Donley to visit many NHS trusts throughout the UK learning and improving his clinical and administrative skills. Dr. Donley was a member of the development team for the Salto Talaris total ankle prosthesis and performed the first surgery in the world with this ankle implant at Cleveland Clinic in 2006. He holds three patents and has over 100 scientific publications.

Contact Information:

Brian Rubin, MD, PhD is Professor and Chair of Pathology, and Director of Soft Tissue Pathology of the Robert J. Tomsich Pathology and Laboratory Medicine Institute at the Cleveland Clinic. He received his PhD in molecular biology and his MD from Cornell University Medical College. He did his residency in Anatomic Pathology at Brigham and Women’s Hospital and received fellowship training in soft tissue pathology, bone pathology, and cancer genetics.
 
Dr. Rubin has dedicated his career to a better understanding of the diagnosis and classification of soft tissue neoplasms, especially sarcomas, where he is a prominent figure nationally and internationally. He is widely regarded as a thought leader in the field and is a founding member of the International Society of Bone and Soft Tissue Pathology. His laboratory is focused on understanding the pathogenesis of sarcomas with the major aim of developing targeted therapies. Dr. Rubin has published over 200 peer reviewed journal articles and is the author of numerous reviews and book chapters. He was a member of the working group that authored the WHO Classification of Tumours of Bone and Soft Tissue in 2002 and 2012. He is well known for his work on gastrointestinal stromal tumor (GIST) and other cancers such as melanoma that are driven by oncogenically-activated KIT receptor tyrosine kinase. His group also characterized a novel gene fusion in epithelioid hemangioendothelioma (EHE), a sarcoma with endothelial differentiation. This latest development has allowed them to initiate studies of EHE biology with the goal of developing targeted therapies to treat EHE. Finally, Dr. Rubin has led his team in the Robert J. Tomsich Pathology and Laboratory Medicine Institute to launch, expand, and maintain SARS-CoV-2 (COVID) testing during the recent unprecedented pandemic.
 

Contact Information:

Charis Eng, MD, PhD, is Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine, an ACS Clinical Research Professor and the inaugural Chairwoman of the Cleveland Clinic’s Genomic Medicine Institute and Director of its clinical component, the Center for Personalized Genetic Healthcare.  As such, she leads the genomics efforts across the global enterprise.  Dr. Eng also is Professor and Vice Chair of the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine. A physician-scientist, She is the go-to person in genomics-informed precision healthcare. With over 500 peer-reviewed articles, she is an elected member of the National Academy of Medicine, and recipient of the American Cancer Society Medical of Honor, among numerous awards. Last year, Dr. Eng was named as the top 0.01% of all scientists in the world across all scientific topics. She has served as advisory to DHHS Secretary’s Committee on Genetics, Health & Society.  Dr. Eng is founder and pro bono Chief Medical Officer of Family Care Path, Inc. and Covariance, LLC.
 

Contact Information:

Christina Farr is a technology and health reporter for CNBC.com in San Francisco. She most recently was a senior writer at Fast Company, covering biotech and health-tech for digital and print, and an Apple reporter at Reuters News. She hails from London, UK and is a graduate of Stanford’s School of Journalism. Reach her on Twitter (@chrissyfarr).

Contact Information:

As Vice President of Venture Capital at Medtronic, Dave works closely with Medtronic’s leadership and business development teams regarding minority investments. He has lead a large number of investments and has served as a Director or Observer on over 15 Boards including superDimension, Medina, Setpoint, PQ Bypass, MD Revolution and numerous undisclosed companies. Prior to Medtronic, Dave served in similar roles at Covidien and Stryker. While at Covidien, he also led a process to develop a white space growth strategy for the company. Earlier in his career, Dave was a healthcare-focused strategy consultant, supporting clients on decisions regarding internal product development and acquisition opportunities across the medical device, diagnostic and biopharmaceutical industries. He received a Ph.D. in molecular biology from the University of British Columbia, and an MBA from Yale.  Insert Bio

Contact Information:

Dave Fredrickson was appointed EVP, Global Head Oncology Business Unit (OBU) in October 2017 and is responsible for driving growth and maximizing the commercial performance of the AstraZeneca global oncology portfolio. In addition, Dave plays a critical leadership role defining and delivering the oncology strategy for the company with accountability for marketing, sales, medical affairs and market access both globally and in major markets.
 
Since joining AstraZeneca in 2014, Dave has held several leadership positions of increasing responsibility, including Vice President, Specialty Care for AstraZeneca in the United States and President of AstraZeneca K. K. in Japan. During his time in Japan, Dave also served as Vice Chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan and was a member of the Board of Directors for the Japan Pharmaceutical Manufacturers Association (JPMA). Before joining AstraZeneca, Dave worked at Roche/Genentech, where he served in several functions and leadership positions, including Oncology Business Unit Manager in Spain and strategy, marketing and sales roles in the US. Before joining Roche/Genentech, Dave worked at the Monitor Group, LLC (now Monitor Deloitte Group, LLC), a global strategy consultancy. Dave is a graduate of Georgetown University in Washington, DC.
 

Contact Information:

Department Chair, Obstetrics & Gynecology

Contact Information:

Elliott Dasenbrook, MD MHS, is the Director of the Cleveland Clinic Adult Cystic Fibrosis Program and the Bronchiectasis Center in the Respiratory Institute. Dr. Dasenbrook trained in the care of individuals living with cystic fibrosis at Johns Hopkins Hospital under the mentorship of Dr. Michael Boyle. Dr. Dasenbrook is known around the world for his expertise in the management of difficult to treat infections. As a member of a multidisciplinary CF team at the Cleveland Clinic, Dr. Dasenbrook partners with his patients to meet their individual goals in order to optimize health outcomes. He has been involved in the care of individuals with CF for more than 10 years and believes that the most important member of the CF team is the patient. Dr. Dasenbrook is a member of the National Cystic Fibrosis Access to Care Committee which is comprised of patients, family members, and clinicians to identify barriers and solutions to improve access to care in the United States. He alsoparticipates in Research and is the Associate Chair of the National CF Foundation Patient Registry Committee.

Contact Information:

Dr. Eric Fung is Vice President, Clinical Development at GRAIL, where he leads several clinical development programs in support of the development of a blood-based multi-cancer detection test. Dr. Fung has previously held clinical development and R&D leadership roles at Affymetrix, Vermillion, Ciphergen, and Roche Molecular Diagnostics. Dr. Fung has led clinical trials leading to FDA clearance of multiple IVD products. Dr. Fung received his MD, PhD from the Johns Hopkins University School of Medicine.

Contact Information:

Eric Walli is the Division Manager of Regional Planning for American Honda Motor, Inc., with responsibility for the long-term strategy development for Honda’s regional companies covering automotive, powersports and power equipment businesses. Walli is also responsible for creating and leading Honda North America’s sustainability office.
 
Prior to this, Walli was the Department Manager of Strategic Engineering where he led a newly-formed organization designed to promote manufacturing-based research and innovation along both technical and business domains.
 
After joining Honda in January 1995, Walli served on the engineering staff where he was responsible for the electrical design of equipment used to manufacture automobiles in the Weld and Stamping areas of OEM production. He became an engineering coordinator in 1998 and moved to Strategic Planning in 2002 where he was responsible for analyzing and measuring manufacturing metrics in order to identify improvement and flexibility opportunities throughout Honda’s automobile production facilities.
 
In 2004, Walli was promoted to Assistant Manager of Strategic Planning for Honda’s non-synchronous parts business for North America automobile production.
 
He became a Manager in 2007 and was responsible for Honda North America’s automobile production allocation. Walli then led the development of production technology strategy for Honda North America, Inc., fostering collaboration across manufacturing, design and procurement divisions.
 
A native of Logan, Ohio, Walli is a graduate of The Ohio State University, where he earned a bachelor’s degree in electrical engineering as well as master’s degree in business administration from the Fisher College of Business.
 
In addition to his role at American Honda Motor, Walli serves on the Mid-Ohio Regional Planning Commission’s (MORPC) Sustainability Advisory Board & Attributable Funds Committee, the Ohio Fuel Cell Coalition (OFCC) Board, and the Grandview Heights Parks and Recreation Advisory Board.  He also serves as a guest lecturer at The Ohio State University Fisher College of Business.
 

Contact Information:

Gail K. Boudreaux is President & CEO of Anthem, Inc., a Fortune 50 company and leading health benefits provider, serving nearly 41 million insured members through its affiliated health plans. In total, Anthem serves over 79 million lives across 27 states through its broad portfolio of health insurance and services subsidiaries.

Throughout her more than three decades in the healthcare industry, Ms. Boudreaux has established an outstanding record of successfully leading multi-billion dollar businesses. As former CEO of United Healthcare, Ms. Boudreaux led the largest business division of UnitedHealth Group, where she had responsibility for approximately $120 Billion in revenue and managed more than 60,000 employees serving 45 million consumers. Prior to United Healthcare, Ms. Boudreaux served as Executive Vice President of Health Care Services Corporation and earlier as President of Blue Cross/Blue Shield of Illinois. Ms. Boudreaux currently serves on the board of directors for Zimmer Biomet Holdings. She earned a bachelor’s degree with honors from Dartmouth College and an MBA with distinction from Columbia Business School.

Gail has been named as one of Fortune Magazine’s Most Powerful Women in Business…and featured by Forbes as one of 100 Most Powerful Women in the World. Additionally, she has been named by Modern Healthcare as one of the 100 Most Influential People in Healthcare, and she also received the 2018 Billie Jean King Leadership Award.

Contact Information:

Gianrico Farrugia, M.D., president and CEO of Mayo Clinic, leads one of the largest not-for-profit, academic health systems in the U.S., with a 70,000-person workforce and $14 billion in annual revenue. Mayo Clinic focuses on patients with serious or complex illnesses, caring for more than 1.2 million unique patients each year from all 50 states and nearly 140 countries. Mayo Clinic is ranked No. 1 in the nation by U.S. News & World Report. 

Prior to his appointment as president and CEO, Dr. Farrugia served as CEO of Mayo Clinic in Florida. Under his leadership, Mayo Clinic in Florida established itself as the destination medical center for the Southeast. He also led Mayo Clinic’s Center for Individualized Medicine, which brings genomics into routine clinical care, and co-founded Mayo Clinic’s Center for Innovation. He is a member of the Mayo Clinic Board of Trustees and Mayo Clinic Board of Governors, and is a professor of medicine and physiology, Mayo Clinic College of Medicine and Science.

Dr. Farrugia has been a Mayo Clinic physician for 30 years. He is jointly appointed in the Division of Gastroenterology and Hepatology, Department of Internal Medicine, and the Department of Physiology and Biomedical Engineering. He completed his undergraduate training at St. Aloysius College and earned his medical degree from the University of Malta Medical School.

Dr. Farrugia is immediate past president of the American Neurogastroenterology and Motility Society. He is the co-author of “Think Big, Start Small, Move Fast: A Blueprint for Transformation From the Mayo Clinic Center for Innovation,” a book highlighting the need for change in the delivery of health care. In addition, he has published more than 300 articles on genomics and the treatment of disorders of gastrointestinal motility. Dr. Farrugia is a member of the Minnesota Business Partnership and is a healthcare governor at the World Economic Forum.

Contact Information:

Ginger Christ is the post-acute care and staffing reporter for Modern Healthcare and is based in Northeast Ohio, where she grew up. Most recently, she wrote about healthcare and transportation for The (Cleveland) Plain Dealer. Before that, she covered real estate, manufacturing and business news for local newspapers and national magazines, starting in 2007. She is the co-founder of the Cleveland chapter of the Association of Health Care Journalists, is on the board of the Press Club of Cleveland and is involved in various efforts to connect and support journalists in her community.

Contact Information:

Hany Aly, MD, FAAP, is the Chair of the Department of Neonatology at Cleveland Clinic Children’s and Professor of Pediatrics at Case Western Reserve University.  Dr. Aly received his Bachelor of Medicine and Bachelor of Surgery from Ain Shams University School of Medicine in Cairo, Egypt.  He completed his residency training at the Department of Pediatrics at Hahnemann University Hospital in Philadelphia, PA, from 1991-1994, and a Postdoctoral Fellow in Neonatal- Perinatal Medicine at Columbia University College of Physicians & Surgeons in New York from 1994-1997. He worked as attending neonatologist at Children’s National Medical Center and the director of Newborn Services at the George Washington University Hospital. He received a Master degree in Healthcare Quality in 2018.   

Dr. Aly is the recipient of the Patient Safety award from the District of Columbia Hospitals Association related to his efforts to control infections during his work as the director of newborn services at the George Washington University Hospital.  

Currently, Dr. Aly is Editor-in-Chief of the Journal of Neonatal-Perinatal Medicine and has extensively published in and reviewed for many journals and written several book chapters. He served as a  member of several societies and committees, including the Heart, Lung and Blood Institute at NIH as a Special Volunteer and the District of Columbia Child Fatality Review Committee. He is a member of the American Academy of Pediatrics, American Pediatric Society and the Society of pediatric Research. 

Dr. Aly had more than 130 peer reviewed papers and 140 conference presentations.  He supervised many international PhD theses and coauthored numerous papers with these collaborators.  He served as a visiting professor for multiple international universities particularly in Egypt.  

Contact Information:

Heath Rigsby is Vice President and Commercial Leader of the Out of Home business for The Clorox Company, a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and sales of $6.7 billion.

Since joining Clorox in 2001, Heath has held domestic and international sales, marketing and general management positions in both the consumer and professional markets including most recently Vice President of International Sales and Vice President of Professional Products Sales. In his current role, Heath leads the newly formed Clorox Out of Home group, a multi-functional team charged with building alliances and partnerships with global multinational organizations.

Prior to joining Clorox, Heath worked for Procter & Gamble. He has an M.B.A. from the University of Tennessee and a B.S. from The University of North Carolina at Chapel Hill.

Contact Information:

Herbert P. Wiedemann is Chief of Staff of Cleveland Clinic.  Dr. Wiedemann joined the physician staff of Cleveland Clinic in 1984. In 1991, he was appointed Chairman of the Department of Pulmonary and Critical Care Medicine.  He held this position until 2007, when he became Chairman of the newly created Respiratory Institute, which subsequently grew to comprise four departments (Pulmonary, Critical Care, Allergy/Clinical Immunology, and Infectious Disease). In March 2018, Dr. Wiedemann was appointed Chief of Staff.

Dr. Wiedemann is recognized by his peers as an excellent clinician; he has been listed in Best Doctors in America (Woodward/White, Inc) since its inception in 1992 and America’s Top Doctors (Castle Connolly Medical, LTD) since its inception in 2001.

As an investigator, Dr. Wiedemann developed and evaluated new treatments for patients with sepsis and the acute respiratory distress syndrome (ARDS).  He received NIH funding for 26 years, in large part for his leadership in the ARDS Clinical Trial Network (“ARDSnet”).  Dr. Wiedemann was principal investigator for one of the ARDSnet’s most impactful and frequently cited trials. Dr. Wiedemann also has extensive experience in the monitoring of clinical trials, having served on the Data Safety Monitoring Board, often as chair, for over 20 major trials or consortia, including several for the NIH.  He has also served as a consultant to the CDC, WHO, and NIH.

Dr. Wiedemann served as a member of the American Board of Internal Medicine’s Subspecialty Board on Pulmonary Disease (1998-2004).

At the Cleveland Clinic, Dr. Wiedemann served as President of the Medical Staff (1995-1996), Editor-in-Chief of the Cleveland Clinic Journal of Medicine (1993-1995), and member of the Board of Governors (2001-2006). In 2008, he was awarded the Maria & Sam Miller Professional Service Award for Scientific Achievement in Clinical Research.

Dr. Wiedemann graduated from Yale College and Cornell Medical School. He earned an MBA from Yale University School of Management. He received his residency training in internal medicine at the University of Washington and fellowship training in pulmonary and critical care medicine from Yale University.

Contact Information:

Jacqueline Law, Ph.D., is the VP & Global Head of Personalized Healthcare Data Science at Genentech/Roche. In this role, Jacqueline leads a team of data scientists with expertise in omics, imaging and Real-World Data (RWD) analysis. The RWD team is responsible for RWD strategy and implementation for late stage development, medical affairs and market access across all therapeutic areas including oncology, neuroscience, infectious disease, inflammation and ophthalmology. Law has been with Genentech/Roche for 16 years and has led quantitative science teams in both Pharma and DIA divisions. Law received her Ph.D. in Biostatistics from the University of California, Los Angeles.

Contact Information:

James Merlino, MD, Chief Clinical Transformation Officer, is responsible for helping to advance the success of Cleveland Clinic’s performance and supporting its vision to become the best place to receive care anywhere. Dr. Merlino oversees Enterprise Safety and Quality, the Office of Patient Experience and Continuous Improvement.
 
With over 30 years of healthcare experience, Dr. Merlino rejoined Cleveland Clinic in December 2019 following nearly five years at Press Ganey. At Press Ganey he served as President and Chief Medical Officer of the strategic consulting division since 2015, and in 2018, he took on the expanded role of Chief Transformation Officer at Press Ganey. He led the development of an integrated organizational strategy to broaden the definition of patient experience to include safe, high quality, patient centered care situated on a foundation of an aligned and engaged healthcare culture. The team grew to be recognized by Consulting Magazine as one of the top 10 fastest growing consulting organizations in the United States three years in a row, and in 2018 and 2019, Press Ganey achieved the Forbes designation as one of the “best management consulting firms.”
 
Dr. Merlino has led C-suite strategic sessions with more than 70 of the largest and most successful healthcare organizations in the United States, and regularly coached CEOs, C-suite leaders and healthcare boards on healthcare strategy. Prior to joining Press Ganey, Dr. Merlino served as Chief Experience Officer and Associate Chief of Staff at Cleveland Clinic, as well as a practicing staff colorectal surgeon in the Digestive Disease and Surgery Institute.
 
Recognized as an expert in improving the patient experience, Dr. Merlino is frequently invited to speak on strategies to redefine care around the needs of the patient. In 2013, Dr. Merlino was named to HealthLeaders Magazine’s list of “20 people who make healthcare better,” and Becker’s list of top 50 experts in healthcare safety four years in a row (2015, 2016, 2017 and 2018). He has been widely published in academic papers, and in 2014, released his first book, “Service Fanatics: How to Build Superior Patient Experience the Cleveland Clinic Way.” He is an editor of the best-selling safety book “Zero Harm: How to Achieve Patient and Workforce Safety in Healthcare,” released in 2018.
 
Dr. Merlino earned his bachelor’s degree in business administration from Baldwin-Wallace College and a medical degree from Case Western Reserve University School of Medicine. Dr. Merlino completed his general surgery training at University Hospitals of Cleveland and his colorectal surgery fellowship at Cleveland Clinic. He is married to Amy Merlino, MD, who is Cleveland Clinic’s Enterprise Chief Medical Information Officer and a maternal-fetal medicine specialist.
 

Contact Information:

An award-winning journalist, bestselling author, motivational speaker, and women's health & wellness advocate, Joan Lunden has been a trusted voice in American homes for more than 30 years. For nearly two decades, Lunden greeted viewers each morning on Good Morning America bringing insight to the day’s top stories. As the longest running female host ever on early morning television, Lunden reported from 26 countries, covered 5 presidents, 5 Olympics, and kept Americans up to date on how to care for their homes, their families, and their health.

Lunden continues to be one of America’s most recognized and trusted personalities. She is a special correspondent on the TODAY Show, host of the CBS series Your Health, and a sought after speaker and event host throughout the country. On her website JoanLunden.com and social media, women interact with her every day about health, wellness, lifestyle tips, family, and boomer information.

In June of 2014, Lunden was diagnosed with triple negative breast cancer, which required chemotherapy, surgery, and radiation. An eternal optimist, Lunden wanted to turn her diagnosis into an opportunity to help others. She blogged throughout her cancer treatment and wrote a memoir Had I Known, which documents her battle, and reflects on her life and career. Lunden serves as as the face of Amgen’s Breakaway from Cancer and advocates for patients on Capitol Hill, and actively communicates with the cancer community through her social media and on her website.

As a part of the sandwich generation, Lunden’s demographic is far-reaching. She is a mother of 7 including two sets of teen twins. Like many Boomers in America she has juggled being a working mom while caring for an aging parent, and brings this experience to her role as the spokesperson for the nation’s leading senior referral service, A Place for Mom, a company helping caregivers and families find the right care and resources for their loved one.

One of the most visible women in America, Lunden has graced the covers of more than 60 magazines and book covers.  

Lunden has served as national spokesperson for various organizations such as The American Heart Association, The American Lung Association, The American Red Cross, The American Academy of Pediatrics, Amgen’s Breakaway from Cancer, The Colon Cancer Alliance, and Mothers Against Drunk Driving

Joan Lunden’s books include Had I Known; Chicken Soup for the Soul: Family Caregiving; Growing Up Healthy: Protecting Your Child From Diseases Now Through Adulthood; Wake-Up Calls; A Bend in the Road is Not the End of the Road; Joan Lunden’s Healthy Living; Joan Lunden’s Healthy Cooking; Mother’s Minutes; Your Newborn Baby; and Good Morning, I’m Joan Lunden. She also hosts the exercise video Workout America.

Joan Lunden truly exemplifies today’s modern working woman.
 

Contact Information:

Joe co-founded Santé Ventures in 2006 and is nationally recognized for his expertise across healthcare delivery systems, physician associations and compensation models. Prior to founding Santé, he was a healthcare Venture Partner with Austin Ventures and Vice Chair of Ascension Health Ventures’ investment committee. He was also Chief Medical Officer of Providence Health System and Executive Director of the Providence Health Alliance, both of which belong to the Ascension healthcare organization.

Joe currently serves on advisory boards for Health Services Corporation (Blue Cross Blue Shield) and United Healthcare. He is also is on the boards of Cleveland Clinic Innovations, Partners Innovations (Harvard Medical School), The Massachusetts General Hospital, and The Brigham and Women’s Hospital, and is a strategic advisor to Texas A&M School of Engineering. He is board-certified in internal medicine, quality assurance and peer review.

Joe earned his MBA from Baylor University, his MD from Texas A&M University and received his BS from Texas A&M University.
 

Contact Information:

Khaldoun George Tarakji, MD, MPH, is a staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. He is board-certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology and Clinical Electrophysiology.

Dr. Tarakji received his medical degree from the University of Damascus, Syria.  After graduation, he relocated to the United States where he worked as a research associate in cardiovascular medicine at Wayne State University in Detroit, Michigan.

Dr. Tarakji came to Cleveland Clinic in 2000 as a research fellow in the Department of Cardiovascular Medicine. From 2001 through 2004 he was a resident in Internal Medicine at Cleveland Clinic. After completing his residency, he remained at Cleveland Clinic as a clinical associate in the Section of Cardiac Electrophysiology, department of Cardiovascular Medicine. In 2009 Dr. Tarakji completed a fellowship in cardiovascular medicine, followed by a fellowship in electrophysiology, which he completed in 2011 and both at the Cleveland Clinic. He was the recipient of many awards including the Ohio ACC chapter fellows research award in 2006, the Cardiothoracic Annual Research award in 2006, the Cash Memorial Award for clinical research in 2007, and the Irving Dawson Award For Clinical Excellence in 2009 in the department of Cardiovascular Medicine. In 2010 he received a Master’s degree in Public Health from Cleveland State University. He was appointed to the medical staff in 2011.

Dr. Tarakji has authored and co-authored many articles in leading scientific journals including Circulation, Journal of American Medical Association (JAMA), Journal of the American College of Cardiology, and Heart Rhythm. He has also presented at several  national and international medical meetings. He is a member of the American Heart Association, the American College of Cardiology, the Heart Rhythm Society and the Honor Society for Collegiate Schools of Business.

In his leisure time, Dr. Tarakji enjoys photography, biking and hiking. He also is an accomplished classical guitarist, graduating with an “Excellent” rating from the Syrian Ministry of Culture National Conservatory for Classical Music.

Contact Information:

Kristina is Chief of Staff and Investor at Khosla Ventures where she focuses on new investments in areas that can be positively impacted with technology, such as in health, bio, agriculture, food, mobile, and transportation. She sits on boards including Overture Life, Daye, Casca, Spyce, Alivecor, and others. She also works with Vinod Khosla on strategic projects for the firm, and advises portfolio companies on fundraising, product, business development, marketing, and general strategy. 

Previously, Kristina has advised and consulted for dozens of startups across consumer brands, health, mobile/software, food, and hardware. Prior, she was an early employee at venture-backed food startup and then before that, she was a Partner at Andreessen Horowitz helping portfolio companies accelerate go-to-market, product, and business development strategies. Before a16z, she was at lululemon athletica where she was responsible for digital, emerging products and concepts (innovation including new brand strategy, product development/mobile, and international expansion), and strategic partnerships. Kristina holds a Bachelor of Arts from the University of Michigan.
 

Contact Information:

Staff, Neurological Institute

Contact Information:

Healthcare Editor

Contact Information:

As Chief Medical Officer of Pfizer, Mace Rothenberg leads Pfizer’s Worldwide Medical & Safety organization that is responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications.  Dr. Rothenberg is also a member of Pfizer’s Portfolio Strategy and Investment Committee, Worldwide Research, Development, and Medical Leadership Team, and Blueprint Leaders Forum.  Outside of his responsibilities at Pfizer, Dr. Rothenberg co-chairs the Life Sciences Consortium of the CEO Roundtable on Cancer and is a member of the NYU School of Medicine’s Alumni Board of Governors.

Prior to becoming Pfizer’s CMO, Dr. Rothenberg was Head of Clinical Development & Medical Affairs for Oncology from 2008 to 2016 and Chief Development Officer for Oncology from 2016 to 2018, During that period, Dr. Rothenberg’s organization was responsible for the successful development and regulatory approval of 11 new cancer medicines.  Prior to joining Pfizer, Dr. Rothenberg spent 25 years in academia where he focused on early-stage drug development, clinical trial design, and the coordinated laboratory-clinical evaluation of new therapies for gastrointestinal cancers.

Dr. Rothenberg is the recipient of the first Craig Saxton Lifetime Achievement Award from Pfizer, the Lane W. Adams Quality of Life Award from the American Cancer Society honoring him as one of the nation's top cancer caregivers, and the Statesman Award from the American Society of Clinical Oncology honoring him for more than 20 years of service to the organization, the specialty of oncology and cancer patients.  He is a Fellow of the American College of Physicians and the American Society of Clinical Oncology.

Dr. Rothenberg received his BA magna cum laude from the University of Pennsylvania in 1978 and his MD from the New York University School of Medicine in 1982.  He received his post-graduate training in Internal Medicine at Vanderbilt University and in Medical Oncology at the National Cancer Institute. Dr. Rothenberg served on the faculties of the University of Texas Health Science Center–San Antonio (1991-1998) and Vanderbilt University (1998-2008).
 

Contact Information:

MaryAnn Mays, MD, was raised in Cleveland, Ohio. She completed her medical school training at the Medical College of Ohio in Toledo in 1993. She returned to Cleveland to complete her neurology residency training from 1993 to 1997. During her residency she was appointed Chief Resident. Following her residency, she completed a year fellowship in clinical neurophysiology/EMG and neuromuscular disease. She has been a Staff Neurologist at Cleveland Clinic since 1998. In 2005, she was appointed Director of the Neurology residency program. Dr. Mays is board-certified in neurology with additional subspecialty board certifications in clinical neurophysiology and headache medicine. She is one of the physicians at the Center for Headache and Pain within the Neurological Institute. She has many clinical interests, including migraine, menstrual migraine, women’s health issues pertaining to headache including pregnancy and menopause, tension headaches, cluster headaches and chronic daily headaches. Additional interests include resident education.

Contact Information:

Matthew Kull is the enterprise Chief Information Officer at Cleveland Clinic, a global medical system that includes a main campus, 10 regional hospitals, 18 family health centers, and facilities in Florida, Nevada, Toronto, Abu Dhabi and London. He serves with responsibility for all aspects of the Clinic’s enterprise technology.
 
Prior to his role at the Cleveland Clinic, Mr. Kull served as Senior Vice President and Chief Information Officer for Parkland Health & Hospital System in Dallas, Texas. While at Parkland, Matthew lead the technology efforts within the construction of Parkland’s new, fully digital, 2.7 million square foot hospital campus. Upon its opening the new campus was lauded as one of the most technically advanced hospital’s in the world.
 
Mr. Kull is a recognized technology expert with a history of developing innovative and transformational technology strategies for organizations of all sizes across multiple industries. His experience spans over twenty years and a variety of healthcare settings including hospitals, pharmacies, regional oncology and disease management institutions. Mr. Kull has held senior leadership positions at internationally recognized enterprises including AmerisourceBergen, McKesson, and NTT. He has also spent a number of years as a management consultant providing strategic guidance to companies across multiple industries. Notable clients include Shoppers Drug Mart, Accenture, Alcon Laboratories, OncoMed, Eurocopter, Thompson Reuters, TXU Energy, Suez Corporation, Citi Group, and Nokia.
 
Mr. Kull holds a Master of Business Administration degree from Southern Methodist University in Dallas, Texas. He is a Certified Healthcare Chief Information Officer (CHCIO) and maintains professional affiliations with College of Healthcare Information Management Executives (CHIME) and Healthcare Information and Management Systems Society (HIMSS). He has won numerous awards, including Dallas Business Journal’s CIO of the Year.

Contact Information:

Since joining CNBC in April 2014, Tirrell has covered the development of new medicines for Alzheimer’s, cancer and rare diseases, and tracked public health emergencies from Ebola to Zika to the COVID-19 pandemic. Her reporting has also chronicled the massive set of trials seeking to hold the drug industry accountable for the opioid epidemic, market failures that have led to life-threatening drug shortages, and the ongoing fight over the cost of medicines.

Prior to joining CNBC, Tirrell covered the biotechnology industry for Bloomberg News, where she also contributed to Bloomberg Television and Bloomberg Businessweek.

Tirrell holds a master’s degree in journalism from Northwestern University and a bachelor’s degree in English and music from Wellesley College.

Follow her on Twitter @megtirrell.
 

Contact Information:

Dr. Moshe Ornstein is a genitourinary medical oncologist at the Cleveland Clinic Taussig Cancer Institute. He attended Columbia University for graduate school, where he received a degree in biotechnology. Following graduate school, he attended medical school at SUNY Stony Brook. His completed his internal medicine residency and hematology/oncology fellowship at the Cleveland Clinic.

Dr. Ornstein's clinical practice and research are focused on cancers of the genitourinary system, with a particular emphasis clinical trial development and drug discovery. His research has been presented at numerous scientific meetings and published in high impact journals such as the The Journal of Clinical Oncology and The Lancet Oncology.  

Contact Information:

Mudit is a Founding General Partner of Strategic Healthcare Investment Partners (S.H.I.P.), and the CEO and co-founder of NuXcel, a medical device accelerator. Mudit also co-founded and serves as Chairman of the Board of ShiraTronics, Inc., a NuXcel spin off company.  

Mudit has over two decades of medical device industry experience across company formation, R&D, and business development. In addition to his private venture capital experiences at S.H.I.P, and Synergy Life Science Partners, Mudit also brings a strategic investment perspective based on his tenure at Johnson and Johnson Development Corporation. 

Mudit has served on the boards of several medical device companies, from early to commercial growth stage, resulting in successful IPOs and M&A transactions. Mudit currently serves on the boards of CVRx, Inc., ShiraTronics, Inc., Neochord, Inc., NuXcel, and Noctrix, Inc. Some of his prior investments/board responsibilities include Inspire Medical Systems (NYSE: INSP), Irhythm Technologies (NSDQ:IRTC), Aptus Endosystems (Acqd. by Medtronic), CardioMEMS (Acqd. by St. Jude Medical), Impres Medical (Acqd. by J&J), and Neuspera,Inc.  

Mudit also serves on the Board of Visitors of the Graduate School at Duke University, External Advisory Board of John Hopkins University Center for Bioengineering Innovation and Design, and on the Board of One Heart Health, a healthcare non-profit, focused on providing healthcare access to pediatric populations in underprivileged geographies.  

Prior to his investing career, Mudit held operational roles in the Cardiac Rhythm Management Division of Guidant Corporation, and played a key role in developing novel device technologies for heart failure, remote cardiac monitoring, and cardiac ablation. Mudit holds eight issued patents and has authored several peer reviewed publications.

Mudit graduated with a B.E. in Electrical Engineering from REC, Nagpur, India, where he was a gold medal recipient for academic achievements. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.
 

Contact Information:

Dr. Pampee Young, Chief Medical Officer of Biomedical Services of the American Red Cross. Dr. Young provides medical guidance, vision, and strategic direction focused on donor and patient safety objectives for a team of 35 physicians. She also provides leadership and support to the divisions of Scientific Affairs and Transfusion Innovations which are engaged in collaborative research with industry, government agencies and academic centers. Prior to joining the Red Cross, Dr. Young served as a tenured Professor and Medical Director of Transfusion Medicine and the Stem Cell Laboratory at Vanderbilt University Medical Center in Nashville. She has published over 100 publications and invited reviews and serves on several advisory and editorial boards.

Contact Information:

Paul Muret is Vice President of Display, Video and Analytics at Google. In this role, he oversees product management and engineering for YouTube's ads business, DoubleClick, and Google Analytics.

Paul has been instrumental in the development of Analytics since its inception in 2005. Previously, Paul was founder and CEO of two start-ups, including Urchin Software Corporation which was acquired by Google and served as the foundation for what would later become Google Analytics.

Before Urchin, Paul ran Quantified System, Inc., a San Diego-based web development and e-commerce hosting company. Paul — a graduate of the University of California, San Diego (UCSD) — was also a member of the UCSD Space Physics research team where he created visualization systems for large-scale simulations.

 

Contact Information:

Rabi Hanna, MD, is the director of the Pediatric Bone Marrow Transplantation at Cleveland Clinic Children’s Hospital, Department of Pediatric Hematology and Oncology. He sees patients on Main Campus.

Dr. Hanna is board certified in pediatrics and pediatric hematology-Oncology. He earned his medical degree from Aleppo University Faculty of Medicine in Aleppo, Syria. His post-graduate training in USA includes a pediatric residency at Duke University Medical Center in Durham, North Carolina, and a pediatric hematology-oncology fellowship at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital in Seattle, Washington.

Dr. Hanna is a member of several professional organizations, including the American Society of Pediatric Hematology Oncology, American Society of Hematology, and the American Society of Bone Marrow Transplant.

Dr. Hanna has published several research articles in peer-reviewed journals, and has presented at professional association meetings.

His specialty interests include treatment of children with leukemia / Lymphoma and solid tumors that require Hematopoietic Stem Cell Transplantation to consolidate the treatment for their malignant disease, and he also very interested in treatment of inherited non-malignant disorders like primary immunodeficiency like SCID or other inherited metabolic diseases which Hematopoietic Stem Cell Transplantation could offer the potential to restore normal hematological and immunologic function.

He is especially interested in identifying successful conditioning treatments with less side effects especially for non-malignant diseases like hematological diseases (sickle cell disease, thalassemia major, severe aplastic anemia, Fanconi anemia, etc) or primary immune deficiency disorders, such as Severe Combined Immune deficiency, Wiskott-Aldrich Syndrome, and IPEX.

His clinical research is aimed at identifying genetic factors that affect outcomes post bone marrow transplantation from unrelated donor. He is also exploring the role of hematopoietic and mesenchymal stem cells in auto-immune disorders and degenerative disorders.

Contact Information:

Rajeev Venkayya is President of the Global Vaccine Business Unit at Takeda Pharmaceuticals, where he leads a team that is developing vaccines for dengue, norovirus and Zika, and supplying pandemic influenza and other vaccines in Japan. He is an independent member of the board of the Coalition for Epidemic Preparedness Innovations (CEPI), which is funding several COVID-19 vaccine development programs. He is also on the board of the International AIDS Vaccine Initiative (IAVI).

Dr. Venkayya previously served at the White House as Special Assistant to the President for Biodefense. In this role, he was the principal author of the National Strategy for Pandemic Influenza (2005), and he led the development and execution of the companion Implementation Plan. His team conceived the strategy of early, coordinated implementation of non-pharmaceutical interventions to slow the spread of a pandemic virus, now known as the “flattening the curve,” that was described in the US Government’s guidelines on community mitigation of pandemic influenza. 

Prior to joining Takeda, Dr. Venkayya served as Director of Vaccine Delivery at the Bill & Melinda Gates Foundation, where he was responsible for the foundations top two priorities of polio eradication and the introduction of new vaccines into developing countries through Gavi, the Vaccine Alliance. He served on the board of Gavi. 

Dr. Venkayya trained and served on the faculty in Pulmonary & Critical Care Medicine at the University of California, San Francisco. He was a resident and Chief Medical Resident in Internal Medicine at the University of Michigan. He received his M.D. from the Northeast Ohio Universities College of Medicine, where he was inducted into the Alpha Omega Alpha honorary medical society.

Contact Information:

Dr. Richard Zane currently serves as the George B. Boedecker Professor and Chair of the Department of Emergency Medicine at the University of Colorado School of Medicine, Professor of Health Administration at the University of Colorado Business School and Chief Innovation Officer at UCHealth.

Dr. Zane completed medical school at Temple University in Philadelphia followed by residency training in emergency medicine at the Johns Hopkins School of Medicine. Following residency, Dr. Zane joined the faculty at Johns Hopkins as Assistant Chief of Service. In 1998, Dr. Zane joined the faculty at Harvard Medical School and Brigham and Women’s Hospital in Boston.

While in Boston, with funding from the Agency for Healthcare Quality and Research, Department of Homeland Security and Assistant Secretary for Preparedness and Response, he formed collaborative industry partnerships to develop tools for preparedness and response to mass casualty care and disaster. These tools have been used domestically and across the globe for events including the earthquake in Haiti, Hurricane Katrina, the Japan earthquake and tsunami and the Boston Marathon bombing and most recently the flooding in Houston and formed the basis for the WHO guide for hospital preparedness. At Brigham and Women’s and Partners Healthcare, bringing lessons of system response from emergency preparedness, he incorporated these modern industrial engineering and informatics principles into care redesign, access and clinical integration.

In 2012, Dr. Zane was recruited to the University of Colorado School of Medicine and Hospital as the inaugural chair of the department of emergency medicine where he led a massive redesign of emergency services. This successful redesign focused not only on integrating industrial engineering practices but also partnering with industry to integrate patient and data centric technologic solutions into the care process resulting in dramatic improvements in quality, experience and cost. UCHealth University of Colorado Hospital Emergency Department was recently ranked the #2 academic ED in the country by Vizient and this approach to care redesign has been replicated across the UCHealth system in 31 emergency departments, as well as the departments of radiology, surgery, oncology and critical care medicine. UCHealth University of  Colorado Hospital has been visited by over 50 health care systems from across the United States, Europe and Asia where fundamental principles of this approach to care redesign are being emulated and Dr. Zane has been asked to consult for the National Health Service in the UK and Ireland as they grapple with emergency care redesign.

As Chief Innovation Officer for UCHealth, Dr. Zane is focused on the development of novel industry and venture relationships to bring innovative solutions to health care. By partnering with companies, from small start-ups to multinationals, and using the power of data science, remote monitoring and prescriptive intelligence, he is attempting to fundamentally alter and improve the way in which health care is delivered.

In 2016, Dr. Zane co-founded the UCHealth CARE Innovation Center in partnership with CU Innovations. The CARE Innovation Center is the UCHealth clinical-validation sandbox that helps company partners test, pilot, optimize and commercialize the most innovative new technologies in health care. CARE Innovation specializes in fundamentally changing the way health care is delivered to patients and seeks partnerships with digital health companies that challenge the status quo.

Dr. Zane has been widely published in peer reviewed publications, his work has been featured in the Harvard Business Review and Wall Street journal and he was recently named a New England Journal of Medicine Catalyst Thought Leader in Medicine.
 

Contact Information:

Eric A. Klein, MD is the Andrew C. Novick Distinguished Chair of  the Glickman Urological and Kidney Institute and Professor of Surgery in the Lerner College of Medicine of the Cleveland Clinic. Following undergraduate training at Johns Hopkins University, he was a cum laude graduate of the University of Pittsburgh School of Medicine. He subsequently completed residency training in Urology at the Cleveland Clinic and a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. He joined the staff of the Cleveland Clinic in 1989 and currently serves as a member of the Department of Cancer Biology of the Cleveland Clinic Lerner Research Institute, the Taussig Cancer Institute, and the Genitourinary Malignancies Program in the Case Comprehensive Cancer Center.
 
Dr. Klein is a member of numerous professional societies and scientific advisory boards including the Board of Scientific Counselors – Clinical Sciences and Epidemiology of the National Cancer Institute, the American Association of Genitourinary Surgeons, the Clinical Society of Genitourinary Surgeons, the Society of Urologic Oncology, the Society of Pelvic Surgeons, the American College of Surgeons, the American Society of Clinical Oncology, and the American Urological Association. He served as President of the Society of Urologic Oncology from 2009 - 2011.
 
Dr. Klein’s clinical and research interests cover all stages of prostate cancer with a focus on genomics and clinical trials. He was the National Study Coordinator for the NCI-sponsored Selenium and Vitamin E Cancer Prevention Trial (SELECT) and has contributed more than 600 papers to the scientific literature, authored or edited 8 books on urologic malignancies, and serves as the Editor-in-Chief of Urology. He has delivered more than 200 invited scientific lectures including 13 named lectureships, and has served as a Visiting Professor at more than 60 institutions around the world. Dr. Klein was awarded the F. Mason Sones Innovation Award by the Cleveland Clinic in 2009, The Joe V. Meigs Award by the Society of Pelvic Surgeons in 2013 and 2015, was named the Kidney Foundation of Ohio’s Person of the Year in 2017, and has received 5 Career Achievement Awards including a 2014 Presidential Citation from the American Urological Association,  the 2014 Huggins Medal from the Society of Urologic Oncology, the 2015 Philip S. Hench Award from the University of Pittsburgh School of Medicine, the 2020 SUO Medal from the Society of Urologic Oncology, and the 2020 Richard D. Williams, MD Prostate Cancer Research Excellence Award from the Urology Care Foundation. He is currently co-leader of the Cleveland Clinic Lerner Research Institute-designated Prostate Cancer Center of Excellence.
 

Contact Information:

Robert Wyllie, MD, is Chief of Medical Operations at Cleveland Clinic since 2011.  In this position he is responsible for the activities of a variety of units including Business Intelligence, Pharmacy, Continuous Improvement, Hospital Throughput, Surgical Operations, and Critical Care Transport.  Dr. Wyllie also oversees the operations of Service Line Performance Management, driving down the cost of health care while improving quality and enhancing patient experience.  

Cleveland Clinic is a world leader in hospital transfers, with nearly 2000 transfers per month from 48 states and 22 countries.  Cleveland Clinic’s Main Campus is among the largest and busiest hospitals in the United States, with 55,000 admissions in 2012.  As a large academic medical center, Cleveland Clinic’s surgical operations are ranked among the most efficient in the United States, with 80% utilization.  Cleveland Clinic has been recognized by the University Hospital Consortium for its outstanding work in quality and efficiency, winning an award as the Most Improved Hospital among academic medical centers in the United States in 2012. To discuss these activities and accomplishments, Dr. Wyllie is invited each year to the World Conference of Health Care.

Before Dr. Delos Cosgrove, Senior Advisor & Former CEO of Cleveland Clinic, brought him onto his Executive Team, Dr. Wyllie was Chief of Cleveland Clinic Children’s Hospital, Chairman of the Pediatric Institute, and the first holder of the Calabrese Endowed Chair in Pediatrics.  During his five years in the position, Dr. Wyllie recruited 160 physicians and tripled the number of pediatricians and pediatric subspecialists at Cleveland Clinic.  Under his leadership, every pediatric specialty became ranked nationally by US News & World Report, and Cleveland Clinic’s became the highest rated Children’s Hospital in northern Ohio.  He built a system for pediatric care across northeast Ohio, with three level 3 neonatal intensive care units staffed 24/7 by pediatric neonatologists and community hospitals staffed at all times by on-site pediatricians.  Under Dr. Wyllie’s leadership, Cleveland Clinic’s Children’s Hospital grew to be the largest provider of pediatric services in northeast Ohio.

Dr. Wyllie is also a world renowned pediatric gastroenterologist with subspecialty interest in inflammatory bowel disease and complex endoscopic procedures.  He is Board Certified in Pediatrics and Pediatric Gastroenterology and Nutrition, and has been repeatedly named among Castle Connolly’s America’s Top Doctors, Best Doctors in America, and Consumers’ Checkbook Guide to Top Doctors.  Other prominent roles at Cleveland Clinic include Member of the Board of Governors, Vice Chair of the Office of Professional Staff Affairs, and Past President of the Professional Staff.

Dr. Wyllie is a member of the American Society of Gastrointestinal Endoscopy, the American College of Gastroenterology, the American Gastroenterological Association, the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition, the American Academy of Pediatrics, and the Crohn’s and Colitis Foundation of America.  He is editor of a major textbook in pediatric gastroenterology, starting on its fifth edition, and has authored over 130 articles in scientific journals including New England Journal of Medicine, Pediatrics, Journal of Pediatrics, Clinical Pediatrics, Emergency Medicine, American Family Physician, Journal of Nuclear Medicine, Hepatology, and the American Academy of Pediatrics update.  He has presented at more than 185 national and international scientific meetings and has delivered more than 135 presentations at hospitals and medical centers.

Dr. Wyllie graduated with honors from the Indiana University School of Medicine, where he also completed a residency in pediatrics and a fellowship in pediatric gastroenterology and nutrition.  Dr. Wyllie earned membership in Phi Beta Kappa while pursuing his undergraduate degree at Indiana University and received the Lyman Mieks Award as the outstanding student in pediatrics.  His wife, Dr. Elaine Wyllie, is a world renowned pediatric epileptologist at Cleveland Clinic, and their two sons are pursuing exciting careers in science and technology.

Contact Information:

Safra A. Catz has served as chief executive officer of Oracle Corporation since 2014 and a member of the company's board of directors since 2001. She previously served as president of ORacle and has also serves as the company's chief financial officer. Prior to beign named president, Catz held various other positions since starting at ORacle in 1999. She currently serves as a director of The Walt Disney Company and previously served a director of HSBC Holdings plc.

Contact Information:

Simrit Sandhu is the Chief Supply Chain & Support Services Officer at Cleveland Clinic. In this role, Ms. Sandhu leads a multi-disciplinary team that spans sourcing, procurement, materials management, analytics and patient support services (including food service, linen and laundry, patient transport, etc.). Her spend portfolio spans clinical, non- clinical and pharmacy totaling $3.5 billion. She manages these services across Cleveland Clinic’s 18 hospitals, 18 ambulatory care centers and 180+ physician offices.

Contact Information:

Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA. From July 2000 to March 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Lilly, Mr. Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux.

Mr. Bancel currently serves on the board of directors of Qiagen N.V. and previously served on the board of directors of BG Medicine, Inc. and Syros Pharmaceuticals, Inc. (Nasdaq: SYRS). He is currently a Venture Partner at Flagship Pioneering and a trustee of the Museum of Science in Boston. Mr. Bancel holds a Master of Engineering degree from École Centrale Paris (ECP), a Master of Science in chemical engineering from the University of Minnesota, and an M.B.A. from Harvard Business School.

Contact Information:

Mr. Glass is the Chief Financial Officer of the Cleveland Clinic. He joined the Cleveland Clinic in 2002 as the Controller and Chief Accounting Officer and served in that role until 2005, when he assumed his current role. Mr. Glass is responsible for all financial operations of the Cleveland Clinic Health System which includes eleven owned hospitals and two managed hospitals, and over 3,000 employed physicians in the Cleveland Clinic Medical Group. The Clinic has operations in Ohio, Florida, Nevada, Canada, and the United Arab Emirates.

Prior to joining the Cleveland Clinic, Mr. Glass was the Vice President of Finance for MedStar Health, where he spent fourteen years serving in various roles during its growth through mergers and acquisitions during the mid-nineties.

Mr. Glass received a Bachelor of Science degree in Accounting from Towson University and is a Certified Public Accountant. He is a member of the American Institute of Certified Accountants, Ohio Society of Certified Public Accountants, Healthcare Financial Management Association, Health Management Academy, and a Board Member of the Ohio Hospital Association.

Contact Information:

Steven M. Gordon, MD, Chairman and Staff Member in the Department of Infectious Disease and a Staff Member in the Transplantation Center.

He is certified in Internal Medicine, as well as Infectious Disease by the American College of Physicians. His specialty interests include healthcare epidemiology, infective endocarditis, and cardiac device infections

Dr. Gordon earned his medical degree from Cornell University Medical College in New York. He completed an internship and residency in Internal Medicine at the University of Chicago Hospitals and Clinics in Chicago, as well as a residency with the U.S. Public Health Service. He was a Fellow with the Centers for Disease Control, Hospital Infections Program, as well as a Fellow with Emory University Hospital in Atlanta, Ga.

He is a member of several professional organizations, including the Society Healthcare Epidemiology of America  for which served as President of the society (January 2011). He is a Fellow of the Infectious Disease Society of America, a Fellow of the American College of Physicians, and member of  American Society of Transplantation. Dr. Gordon has received a number of honors and awards over the years.  Most recently, he was appointed to serve on the Defense Health Board which serves as a Federal Advisory Committee to the Secretary of Defense.  He has also presented a number of national and international meetings, as well as having published more than 160 articles and multiple book chapters.

Contact Information:

Susan completed her Bachelor of Science in Microbiology from the University of Illinois, C-U and her Master of Business Administration from the University of Nebraska. Susan has more than 30 years of manufacturing experience, including energy, automotive vehicle, powertrain and components assembly. Susan has dedicated her career to improving American manufacturing and assuring that the United States maintains a vital manufacturing footprint, especially in areas of key technological advances. In her time as a manufacturing practitioner, she has always been a strong proponent of sustainability, starting in her first role as the Environmental and Coating Manager with Douglas and Lomason, leading the plant to the State of Iowa's first ever Waste Minimization award to launching the all-electric Nissan Leaf in Smyrna, TN and now the COO of Bloom Energy, in Sunnyvale, CA, bringing reliable #alwayson energy to critical infrastructure including Data Centers, Hospitals, Grocery stores, banks and other essential services. Throughout her career, she has maintained that jobs and the environment can have a symbiotic relationship, and that passion drives her as she pursues her role at Bloom. In addition, she has created and supported organizations that encourage young women to pursue careers in math and science as a way to support future generations of technological manufacturing in the United States. Susan founded Southern Automotive Women’s Forum, a 10 year old 501c3 whose mission to provide professional development for women in automotive and scholarships has changed the face of automotive leadership in the Southeast United States.  Susan is now an ambassador for C3E, a Dept of Energy program tasked with bringing more women into Energy and for professional development of women currently in the energy field.  Both of these organizations support Susan’s passion of building and growing technical fields to be more open and accessible for highly talented and skilled women.
 
Susan shared the story of her career with her Alma Mater, University of Illinois, giving the Molecular and Cellular Biology Commencement speech in 2019 to tell her story of how a technical degree can have a rewarding and exciting path for those who are willing to take on the challenge.
 

Contact Information:

Toby Enqvist is the senior vice president and chief customer officer at United. He is responsible for overseeing our inflight services, corporate real estate, contact centers and customer care, customer strategy and innovation, and customer experience and analytics. 

Toby has been in the airline industry for over 24 years, joining Continental in 1996. During these 24 years with Continental and United Airlines, Toby has held several senior leadership positions within operations and finance. Toby was most recently senior vice president of network operations and customer solutions for United. In addition to overseeing the day-to-day operations of the airline in the areas of operational control, he was and still is responsible for overseeing contact centers and customer care teams. Another part of his past and current experience is developing and giving our front-line employees the tools, policies and processes needed to succeed at their jobs on a daily basis.

Born and raised in Stockholm, Sweden, Toby moved to the U.S. to attend Ouachita Baptist University on a tennis scholarship, where he earned his bachelor’s degree in business administration. He received his Master of Business Administration from Southern Methodist University in Dallas, Texas. He is also a member of the Northwestern University Business Advisory Council. He is married and has a daughter.

Contact Information:

Tom Lawry serves as National Director of AI for Health & Life Sciences at Microsoft and previously served as Director of Worldwide Health. Tom works with providers, payors and life science organizations in planning & implementing innovative analytical solutions that improve the quality and efficiency of health services delivered around the globe.

Tom focuses on strategies for digital transformation applied to performance optimization including Artificial Intelligence (AI), Machine Learning (ML) and Cognitive Services.  He previously served as Director of Organizational Performance for Microsoft’s health incubator (Health Solutions Group).

Prior to Microsoft Tom served as a Senior Director at GE Healthcare with global responsibilities for revenue cycle management analytics and operational performance solutions.

Lawry was founder and CEO of Verus, a healthcare software company named as one of the Top 100 Fastest Growing Washington Companies for three consecutive years and to the Deloitte Fast 500 Technologies list.
For twelve years Lawry served in various executive management roles in hospitals and integrated delivery networks. He has published numerous articles on topics relating to use technology to innovate healthcare. His new book from HIMSS & CRC Press is: Artificial Intelligence in Healthcare: A Leader’s Guide to Winning in the New Age of Intelligent Health Systems.


 

Contact Information:

Tom Mihaljevic, MD, is CEO and President of Cleveland Clinic. He leads an $8 billion medical system that includes a main campus, 10 regional hospitals, 18 family health centers, and facilities in Florida, Nevada, Toronto, Abu Dhabi and London. Representing a new generation of leadership for American’s #2 ranked hospital (U.S. News & World Report), Dr. Mihaljevic seeks to build on Cleveland Clinic’s reputation for medical expertise, to enhance the patient experience, and expand access to clinical services. Dr. Mihaljevic joined Cleveland Clinic in 2004 as a surgeon in the Department of Thoracic and Cardiovascular Surgery. He has performed almost 3,000 operations over the course of his career, specializing in minimally invasive and robotic-assisted procedures, valve replacement and repair, image-guided surgery, heart failure and cardiac transplantation. He earned his medical degree at the Medical School, University of Zagreb, Croatia. He trained in cardiac surgery at the University of Zurich, Switzerland. In the United States, he did residencies in general and cardiothoracic surgery at Brigham and Women’s Hospital, and was chief resident in the Department of Cardiovascular Surgery at Boston Children’s Hospital. Before coming to Cleveland Clinic, Dr. Mihaljevic was director of the Cardiac Surgery Research Laboratory and an associate surgeon in the Division of Cardiac Surgery at Brigham and Women’s Hospital in Boston. Dr. Mihaljevic held a seven-year academic appointment to Harvard Medical School as a Clinical Fellow in Surgery. He was also Assistant Professor of Surgery at Harvard Medical School. From 2015-2017, Dr. Mihaljevic served as CEO of Cleveland Clinic Abu Dhabi (CCAD). He oversaw the opening of the 365-bed hospital and clinic, with 3,000 caregivers, in 2015. Under his leadership, CCAD expanded its treatment capabilities, built relationships in the private and public sector, and established its growing reputation for clinical excellence, research and education. From 2010 to 2015, Dr. Mihaljevic was Chief of Staff and Chairman of the Heart & Vascular Institute at CCAD. He led a recruitment effort that drew 5,500 applications for 175 physician posts, and went on to launch the most advanced cardiovascular program in the Middle East.

Contact Information: